ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years

October 25, 2013

ASCO Updates Guideline On Antiemetics

June 30, 2006

Trials Approved by NCI CTEP For the Month of January

January 27, 2012

Cancer Care Act Introduced In Senate.

April 18, 2008

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

July 30, 2004

Appropriations 2014: Obama Plan Good News for NIH, Bad News For Some Oncologists

April 12, 2013